Emerson Q3 sales, adjusted EPS beat estimates; raises 2026 outlook
EMR•Raised 2026 outlook
Emerson raised its 2026 net sales growth outlook to about 5%.
The company now sees 2026 adjusted EPS at about $6.55.
Emerson expects to return about $2.2 billion to shareholders in 2026 via buybacks and dividends.
Demand and margin drivers
The company said underlying orders rose 7%, led by Software & Systems and broad-based growth in North America and Asia.
Adjusted segment EBITA margin increased to 28.5% from 27.1% a year earlier.
Management said secular tailwinds are supporting sustained investment in growth verticals.
Q3 results beat estimates
Emerson's fiscal Q3 net sales rose 7%, beating analyst expectations. Adjusted EPS for fiscal Q3 increased 13%, also beating analyst expectations.
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q3 Sales | Beat | $4.87 bln | $4.80 bln (18 Analysts) |
| Q3 Adjusted EPS | Beat | $1.71 | $1.68 (19 Analysts) |
| Q3 EPS | $1.28 | ||
| Q3 Net Earnings | $718 mln | ||
| Q3 Operating Cash Flow | $1.43 bln |
Analyst coverage and valuation
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 20 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell".
